It is extremely encouraging that in less than 6 years CART-19 went from new clinical trial status to Food & Drug Administration (FDA) approval for treatment. The very first FDA approved immunotherapy treatment was for an adult prostate cancer in 2010. In 2011, six-year old Emily Whitehead received the first pediatric trial of a novel…
Tag Archives: Dr Michael Jensen
Very good news for young cancer patients
The Seattle Times recently ran an article in which they featured a “promising Seattle Children’s clinical trial”. You guessed right, they are talking about our very own Dr. Jensen and the amazing success he is having. Please be sure to read the full article so you can get a glimpse into where Make Some Noise…
$105,000 presented to Children’s Hospital
Dr. Jensen, the Director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Hospital, received a grant check for $105,000.00 from Jack Sutherland, President and CEO of Make Some Noise- Northwest and Junior Board members Maxsena Butler, Tally Black Brown, and Ben LaRoche. The grant consisted of funds realized from “The Cure…
FDA approves second pediatric leukemia T cell therapy
Dr. Michael Jensen of Seattle Children’s has announced the FDA approval of the second pediatric leukemia T cell therapy, allowing patients between the ages of 12 months and 27 who have relapsed after bone marrow transplantation. This allows for treatment on an accelerated basis with the latest version of reprogrammed T cells. For many children,…
Another T cell immunotherapy success
Another miraculous T cell immunotherapy success is reported. Seattle Children’s Hospital Research Institute announced on February 18 that patient Milton Wright III, diagnosed for the third time with leukemia and given little chance of survival, was infused with his own reprogrammed T cells and within two weeks was leukemia free. This is the second encouraging…
Juno biotech launch focuses on immunotherapies for cancer
The Fred Hutchinson Cancer Research Center (Fred Hutch) and Memorial Sloan-Kettering Cancer Center (MSKCC), along with pediatric partner Seattle Children’s Research Institute, have joined forces to launch Juno Therapeutics Inc., a new biotechnology company focused on bringing forward novel immunotherapies for cancer. Juno is being launched with an initial investment of $120M, making it one…
Grant presented for Immunotherapy clinical trials
The $35,000.00 grant presented to Dr. Michael C. Jensen on July 22 by Northwest Chapter President Jack Sutherland and Treasurer Eric Gjelde (see photo, above) brings the Make Some Noise total to date to $115,000. This and future grants will go to Immunotherapy clinical trials. Dr. Jensen is Director of the Ben Towne Center for…
Noise Night Northwest
Noise Night Northwest, a benefit concert on May 10 at the Treehouse Café in Lynwood Center, packed the house for live musical entertainment by Eilen Jewell, food and drinks, and a stimulating presentation by Dr. Michael Jensen on immunotherapy research. The alt-country musical talent helped to raise over $5,000 for kids cancer research at Seattle…
Dr. Jensen named to North America Dream Team
Dr. Michael C. Jensen, Director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Hospital Research Institute, was named to the North America Dream Team. He will participate in a St. Baldrick’s Foundation grant of $1.86 million at Seattle Children’s, and be part of a $14.5 million grant to a total of…
NW Chapter Kick-Off
The Make Some Noise – Northwest Chapter Kick-Off on April 21, 2012 was attended by the National’s Founder and President. An auction and reception provided $20,000 to Dr. Michael C. Jensen’s research work at Seattle Children’s Hospital Research Institute—added to the National’s earlier donation of $60,000. The Northwest Chapter was incorporated as a Washington non-profit…